AvsMEDP
Agilent Technologies IncvsMedpace Holdings Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
Agilent Technologies Inc
$114.42
-17.80%
Medpace Holdings Inc
$393.42
-29.59%
60-day price, rebased to 100
Round-by-round
Valuation upside
-35.10% vs +23.40% to DCF fair value
Balance-sheet strength
Altman Z 4.71 vs 7.23
Fundamental quality
Piotroski 4.00 vs 6.00 (of 9)
Growth + margins
Rule-of-40 16.60 vs 46.90
60-day momentum
-14.52% vs -32.46% price return
Market-cap liquidity
$34.0B vs $14.1B
Verdict
Across6categories,MEDPtakes the edge with4wins to2. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy onAorMEDP
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.